OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase I study of phenylacetate administered twice daily to patients with cancer

HTML

Year: 1995
Type: article
Study design: Clinical Trial
Source: Cancer
DOI: 10.1002/1097-0142(19950615)75:12<2932::aid-cncr2820751221>3.0.co;2-p
Authors: Alain Thibault, Dvorit Samid, Michael R. Cooper, William D. Figg, Anne C. Tompkins, Nicholas Patronas, Donna J. Headlee, David R. Kohler, David J. Venzon, Charles E. Myers
Institutions: National Institutes of Health, National Cancer Institute, National Institutes of Health Clinical Center
Language: English

Topic: Cancer therapeutics and mechanisms
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: sodium phenylacetate, anticancer agents, nonlinear pharmacokinetics, drug accumulation, central nervous system depression, drug metabolism, high-grade glioma, castration-resistant prostate cancer, intermittent dosing, tumor growth inhibition
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W1966191179
FWCI: 2.386
Cites: 29
Cited by: 129
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms